Methotrexate for severe vulvar lichen sclerosus
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study tests the drug methotrexate as a treatment for severe vulvar lichen sclerosus that has not responded to strong steroid creams. It aims to see if methotrexate can reduce symptoms and prevent further scarring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have lichen sclerosus on your vulva, perineum, or anal area, confirmed by a skin biopsy.
- Your symptoms have not improved after using a strong corticosteroid cream for at least 3 months.
- You have significant discomfort, with a score over 24 on a quality-of-life questionnaire.
- Your blood tests (including liver, kidney, blood cell counts) are normal, and you are not infected with HIV or hepatitis B/C.
- If you can become pregnant, you have a negative pregnancy test and agree to use effective birth control during the study.
- You must not plan to become pregnant, must avoid heavy alcohol use, and must be able to attend study visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new topical treatment, StrataMGT, can reduce symptoms of vulvar lichen sclerosus. It is for women with moderate to severe symptoms who are already using a stable topical prescription.
This trial compares three treatments for vulvar lichen sclerosus: a steroid ointment, a non-steroid ointment, and platelet-rich plasma therapy. It aims to see which works best for managing symptoms and improving skin health.
This study compares a new non-invasive treatment using radiofrequency energy to a standard steroid cream for women with vulvar lichen sclerosus. The goal is to see which works better for symptom relief.
This trial compares two medications, hydroxychloroquine and methotrexate, to see which works better for treating lichen planopilaris (a scalp condition that causes hair loss). Patients can choose their treatment or be assigned based on their health needs.
This study compares two systemic medicines, methotrexate and acitretin, to see which works better for people with generalized lichen planus (a skin condition affecting large areas of the body). It may help find a more effective treatment option.
This study tests if a new drug called nemolizumab can help reduce itch in women with lichen sclerosus (LS) in the genital area. Participants must have tried topical steroids before.
Hear when a new Vulvar Lichen Sclerosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.